Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-27270
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSchneider, Lukas-
dc.contributor.authorKalt, Martina-
dc.contributor.authorKoch, Samuel-
dc.contributor.authorSithamparanathan, Shanmugi-
dc.contributor.authorVilliger, Veronika-
dc.contributor.authorMattiat, Johann-
dc.contributor.authorKradolfer, Flavia-
dc.contributor.authorSlyshkina, Ekaterina-
dc.contributor.authorLuber, Sandra-
dc.contributor.authorBonmarin, Mathias-
dc.contributor.authorMaake, Caroline-
dc.contributor.authorSpingler, Bernhard-
dc.date.accessioned2023-03-11T11:41:12Z-
dc.date.available2023-03-11T11:41:12Z-
dc.date.issued2023-03-01-
dc.identifier.issn0002-7863de_CH
dc.identifier.issn1520-5126de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/27270-
dc.description.abstractHere, we report six novel, easily accessible BODIPY-based agents for cancer treatment. In contrast to established photodynamic therapy (PDT) agents, these BODIPY-based compounds show additional photothermal activity and their cytotoxicity is not dependent on the generation of reactive oxygen species (ROS). The agents show high photocytotoxicity upon irradiation with light and low dark toxicity in different cancer cell lines in 2D culture as well as in 3D multicellular tumor spheroids (MCTSs). The ratio of dark to light toxicity (phototoxic index, PI) of these agents reaches striking values exceeding 830,000 after irradiation with energetically low doses of light at 630 nm. The oxygen-dependent mechanism of action (MOA) of established photosensitizers (PSs) hampers effective clinical deployment of these agents. Under hypoxic conditions (0.2% O2), which are known to limit the efficiency of conventional PSs in solid tumors, photocytotoxicity was induced at the same concentration levels, indicating an oxygen-independent photothermal MOA. With a PI exceeding 360,000 under hypoxic conditions, both PI values are the highest reported to date. We anticipate that small molecule agents with a photothermal MOA, such as the BODIPY-based compounds reported in this work, may overcome this barrier and provide a new avenue to cancer therapy.de_CH
dc.language.isoende_CH
dc.publisherAmerican Chemical Societyde_CH
dc.relation.ispartofJournal of the American Chemical Societyde_CH
dc.rightsLicence according to publishing contractde_CH
dc.subject.ddc540: Chemiede_CH
dc.subject.ddc616: Innere Medizin und Krankheitende_CH
dc.titleBODIPY-based photothermal agents with excellent phototoxic indices for cancer treatmentde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementSchool of Engineeringde_CH
zhaw.organisationalunitInstitute of Computational Physics (ICP)de_CH
dc.identifier.doi10.1021/jacs.2c11650de_CH
dc.identifier.doi10.21256/zhaw-27270-
dc.identifier.pmid36780327de_CH
zhaw.funding.euNode_CH
zhaw.issue8de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.end4544de_CH
zhaw.pages.start4534de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume145de_CH
zhaw.embargo.end2024-02-13de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.webfeedSensors and Measuring Systemsde_CH
zhaw.author.additionalNode_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen School of Engineering

Files in This Item:
File Description SizeFormat 
2023_Schneider-etal_BODIPY-based-photothermal-agents-cancer-treatment_JACS.pdf5.33 MBAdobe PDFThumbnail
View/Open
Show simple item record
Schneider, L., Kalt, M., Koch, S., Sithamparanathan, S., Villiger, V., Mattiat, J., Kradolfer, F., Slyshkina, E., Luber, S., Bonmarin, M., Maake, C., & Spingler, B. (2023). BODIPY-based photothermal agents with excellent phototoxic indices for cancer treatment. Journal of the American Chemical Society, 145(8), 4534–4544. https://doi.org/10.1021/jacs.2c11650
Schneider, L. et al. (2023) ‘BODIPY-based photothermal agents with excellent phototoxic indices for cancer treatment’, Journal of the American Chemical Society, 145(8), pp. 4534–4544. Available at: https://doi.org/10.1021/jacs.2c11650.
L. Schneider et al., “BODIPY-based photothermal agents with excellent phototoxic indices for cancer treatment,” Journal of the American Chemical Society, vol. 145, no. 8, pp. 4534–4544, Mar. 2023, doi: 10.1021/jacs.2c11650.
SCHNEIDER, Lukas, Martina KALT, Samuel KOCH, Shanmugi SITHAMPARANATHAN, Veronika VILLIGER, Johann MATTIAT, Flavia KRADOLFER, Ekaterina SLYSHKINA, Sandra LUBER, Mathias BONMARIN, Caroline MAAKE und Bernhard SPINGLER, 2023. BODIPY-based photothermal agents with excellent phototoxic indices for cancer treatment. Journal of the American Chemical Society. 1 März 2023. Bd. 145, Nr. 8, S. 4534–4544. DOI 10.1021/jacs.2c11650
Schneider, Lukas, Martina Kalt, Samuel Koch, Shanmugi Sithamparanathan, Veronika Villiger, Johann Mattiat, Flavia Kradolfer, et al. 2023. “BODIPY-Based Photothermal Agents with Excellent Phototoxic Indices for Cancer Treatment.” Journal of the American Chemical Society 145 (8): 4534–44. https://doi.org/10.1021/jacs.2c11650.
Schneider, Lukas, et al. “BODIPY-Based Photothermal Agents with Excellent Phototoxic Indices for Cancer Treatment.” Journal of the American Chemical Society, vol. 145, no. 8, Mar. 2023, pp. 4534–44, https://doi.org/10.1021/jacs.2c11650.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.